TABLE 1.
Baseline characteristics of the study participants.
| Baseline characteristics | MDP (n = 15) | CHD (n = 13) | P-value |
| Sex, n (%) | |||
| Male | 6 (40) | 4 (31) | 0.71a |
| Female | 9 (60) | 9 (69) | |
| Age, (years) | |||
| Median (IQR) | 52 (21) | 39 (24) | 0.30b |
| Min-max | 18–65 | 25–63 | |
| Smokers, n (%) | |||
| Yes | 4 (27) | 3 (23) | >0.99a |
| No | 11 (73) | 10 (77) | |
| Physical activity (>150 min/week), n (%) | |||
| Yes | 12 (80) | 13 (100) | 0.23a |
| No | 3 (20) | 0 | |
| BMI (kg/m2) | |||
| Median (IQR) | 23 (11) | 22 (8) | 0.79b |
| Min-max | 17–30 | 19–29 | |
| BMI classification, n (%) | |||
| Underweight (<18.5) | 3 (20) | 1 (8) | 0.30a |
| Normal weight (18.5 – < 25) | 6 (40) | 9 (69) | |
| Overweight (25.0 – < 30.0) | 5 (33) | 3 (23) | |
| Obese (>30) | 1 (7) | − | |
| Food intolerance, n (%) | 0.25a | ||
| Yes | 7 (47) | 10 (77) | |
| No | 8 (53) | 3 (23) | |
| SaskIBD-NR | |||
| Low risk (0) | 7 (47) | 5 (38) | 0.70a |
| Medium risk (1) | 7 (47) | 8 (53) | |
| High risk (≥2) | 1 (6) | − | |
| Vitamin levels (Median, IQR) | |||
| Vitamin D (ng/ml) | 87 (16) | 96 (34) | 0.21b |
| Vitamin B12 (pg/ml) | 425 (281) | 473 (407) | 0.95b |
| Disease duration, (years) | |||
| Median (IQR) | 10 (29) | 10 (32.5) | 0.72b |
| Min-max | 1–30 | 1–33 | |
| Current medications, n (%) | 0.55a | ||
| No medications | 4 (27) | 2 (15) | |
| 5-aminosalicylic acid | 8 (53) | 10 (77) | |
| Biologic only | 2 (13) | − | |
| Thiopurine + Biologic | 1 (7) | 1 (8) | |
| Partial Mayo score | |||
| Total score (range) | 0 (0–2) | 0 (0–1) | >0.99b |
MDP, Mediterranean diet pattern; CHD, Canada’s Habitual Diet Pattern; IQR, Interquartile range; BMI, body mass index; Sask IBD-NR, Saskatchewan Inflammatory Bowel Disease Nutrition Risk (22). aFisher’s exact test. bMann-Whitney test. Statistically significant difference p < 0.05.